| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |